OpenFilings

Virpax Pharmaceuticals, Inc.

Form10-Q

Report Period2023-06-30

Date Filed2023-08-14

Time Filed09:15:23

Document Analysis

Natural Language Processing

Recognized Type Unidentified

Defined Term Format

Exhibits

QUARTERLY REPORT
CERTIFICATION OF THE CHIEF EXECUTIVE OFFICER PURSUANT TO RULE 13A-14(A) OR RULE
CERTIFICATION OF THE CHIEF FINANCIAL OFFICER PURSUANT TO RULE 13A-14(A) OR RULE
CERTIFICATION OF PRINCIPAL EXECUTIVE OFFICER AND CHIEF FINANCIAL OFFICER PURSUAN
CERTIFICATION OF CHIEF FINANCIAL OFFICER PURSUANT TO RULE 13A-14(B) OR RULE 15D-
Filing on SEC Edgar